Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort
(in billion U.S. dollars)
Characteristic
Original cohort*
Extension cohort**
2018-2020
2.37
-
2017-2019
2.16
2.44
2016-2018
1.85
2.26
2015-2017
1.63
1.63
2014-2016
1.48
1.31
2013-2015
1.41
1.08
2012-2014
1.31
-
2011-2013
1.28
-
2010-2012
1.22
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
This statistic shows the rolling three-year average cost to research and develop a new biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort. In the original study cohort, in the period 2018-2020, the average cost to develop an asset was nearly 2.4 billion U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Deloitte. (May 24, 2021). Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 19, 2026, from /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/
Deloitte. "Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort (in billion U.S. dollars)." Chart. May 24, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 19, 2026. /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/
Deloitte. (2021). Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 19, 2026. /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/
Deloitte. "Three-year Average R&d Cost to Develop a Biopharmaceutical Compound from Discovery to Launch from 2010 to 2020, by Study Cohort (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 May 2021, /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/
Deloitte, Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/ (last visited July 19, 2026)
Three-year average R&D cost to develop a biopharmaceutical compound from discovery to launch from 2010 to 2020, by study cohort (in billion U.S. dollars) [Graph], Deloitte, May 24, 2021. [Online]. Available: /statistics/825754/three-year-average-randd-cost-for-new-pharma-compounds/
